Lu Zang, MDPhD, Wei-guo Hu, MD, Jun-jun Ma, PhD, Bo Feng, PhD, Min-hua Zheng, MD
Department of Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai minimally invasive surgery center, 200025, Shanghai, P. R. China.
OBJECTIVE:The purpose of this study was to evaluate the feasibility, safety and long-term outcomes of laparoscopy-assisted gastrectomy (LAG) with lymph node dissection for early and advanced gastric cancer.
METHODS:209 patients with gastric cancer who received LAG from January 2004 to December 2010 in our hospital were retrospectively reviewed and analyzed. The following items were observed: operative time, blood loss, number of lymph nodes harvested, postoperative complications and long-term oncologic outcomes.Gastric cancer cases were analyzed according to the American Joint Committee on Cancer classification (seventh edition).
RESULTS:170 LADG, 9 LAPG and 30 LATG were performed successfully,Whereas the lymphadectomy of Dl+α, Dl+β, and D2 were 40, 29, and 140 respectively. The mean operative time was 218.3±54.4min; mean blood loss was 191.1±150.7ml; number of lymph nodes harvested was 21.1±11.3 respectively; postoperative complications was 11.9%;No intra/postoperative mortality was observed. Median follow-up was 36 months. The mortality is 15.8%(33/209)and the rate of recurrence is 16.3%(34/209).The overall 5-year survival rate were 80.9%(97.6% in EGC and 58.6% in AGC).The 5-year relapse-free survival rates were 79.6%.
CONCLUSIONS:Our single-center study revealed that LAG for early and advanced gastric cancer had acceptable short-term and long-term oncologic outcomes comparable to those of conventional open surgery.
Session: Poster Presentation
Program Number: P551
sages_adbutler_leaderboard